[C:1]([N:4]1[CH2:9][CH2:8][CH:7]([C:10]([OH:12])=O)[CH2:6][CH2:5]1)(=[O:3])[CH3:2].[OH:13]N1[C:18]2C=CC=[CH:22][C:17]=2N=N1.Cl.[CH2:24](N=C=NCCC[N:32]([CH3:34])C)C.[F:35][C:36]1[CH:42]=[CH:41][C:39](N)=[CH:38][CH:37]=1>ClCCl>[CH:17]([O:12][CH:10]([CH3:7])[CH3:24])([CH3:22])[CH3:18].[C:1]([N:4]1[CH2:5][CH2:6][CH:7]([C:39]2[CH:41]=[CH:42][C:36]([F:35])=[CH:37][CH:38]=2)[CH2:8][CH:9]1[C:34](=[O:13])[NH2:32])(=[O:3])[CH3:2]A mixture of N-acetylpiperidine-4-carboxylic acid (514 mg), 1-hydroxybenzotriazole (405 mg), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (575 mg) and 4-fluoroaniline (284.2 ml) in dichloromethane (5 ml) was stirred for 18 hours at ambient temperature. The mixture was diluted with dichloromethane and washed with water, saturated aqueous sodium hydrogen carbonate, water, and brine. After drying with magnesium sulfate, the solvents were removed under reduced pressure. A residue was purified by column chromatography (silica gel 40 ml, dichloromethane:methanol=15:1). After trituration with diisopropyl ether, 1-acetyl-4-(4-fluorophenyl)-carbamoylpiperidine (532 mg) was obtained.